Stephen L. Rawlings

Array ( [id] => 5786318 [patent_doc_number] => 20020159986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Bone morphogenetic protein-2 in the treatment and diagnosis of cancer' [patent_app_type] => new [patent_app_number] => 10/044716 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12897 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20020159986.pdf [firstpage_image] =>[orig_patent_app_number] => 10044716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 533449 [patent_doc_number] => 07172880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them' [patent_app_type] => utility [patent_app_number] => 10/041859 [patent_app_country] => US [patent_app_date] => 2002-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14137 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/172/07172880.pdf [firstpage_image] =>[orig_patent_app_number] => 10041859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 860175 [patent_doc_number] => 07371574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Antibody antagonists of VE-cadherin without adverse effects on vascular permeability' [patent_app_type] => utility [patent_app_number] => 10/040128 [patent_app_country] => US [patent_app_date] => 2002-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 8973 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371574.pdf [firstpage_image] =>[orig_patent_app_number] => 10040128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728156 [patent_doc_number] => 07041495 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Pregnancy up-regulated, nonubiquitous CaM kinase' [patent_app_type] => utility [patent_app_number] => 10/032254 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19474 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041495.pdf [firstpage_image] =>[orig_patent_app_number] => 10032254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750289 [patent_doc_number] => 20030044809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Nucleic acid binding of multi-zinc finger transcription factors' [patent_app_type] => new [patent_app_number] => 10/028396 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21662 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044809.pdf [firstpage_image] =>[orig_patent_app_number] => 10028396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402410 [patent_doc_number] => 20020182191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Compounds for immunotherapy and diagnosis of colon cancer and methods for their use' [patent_app_type] => new [patent_app_number] => 10/025380 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44715 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182191.pdf [firstpage_image] =>[orig_patent_app_number] => 10025380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761173 [patent_doc_number] => 20030124534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Method of detecting and treating Tuberous Sclerosis Complex associated disorders' [patent_app_type] => new [patent_app_number] => 10/016253 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24346 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124534.pdf [firstpage_image] =>[orig_patent_app_number] => 10016253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 616579 [patent_doc_number] => 07144991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'Streptavidin expressed gene fusions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/013173 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 34 [patent_no_of_words] => 21449 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/144/07144991.pdf [firstpage_image] =>[orig_patent_app_number] => 10013173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446464 [patent_doc_number] => 20020177212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Polypeptide that interacts with heat shock proteins' [patent_app_type] => new [patent_app_number] => 10/013939 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 24828 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177212.pdf [firstpage_image] =>[orig_patent_app_number] => 10013939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733409 [patent_doc_number] => 20080050388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'HUMANIZED COLLAGEN ANTIBODIES AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 10/011250 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24815 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050388.pdf [firstpage_image] =>[orig_patent_app_number] => 10011250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 869061 [patent_doc_number] => 07365167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Humanized collagen antibodies and related methods' [patent_app_type] => utility [patent_app_number] => 09/995529 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24874 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 317 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365167.pdf [firstpage_image] =>[orig_patent_app_number] => 09995529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 869061 [patent_doc_number] => 07365167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Humanized collagen antibodies and related methods' [patent_app_type] => utility [patent_app_number] => 09/995529 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24874 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 317 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365167.pdf [firstpage_image] =>[orig_patent_app_number] => 09995529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6751183 [patent_doc_number] => 20030045704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes' [patent_app_type] => new [patent_app_number] => 09/988687 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 39986 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045704.pdf [firstpage_image] =>[orig_patent_app_number] => 09988687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684188 [patent_doc_number] => 20030120052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes' [patent_app_type] => new [patent_app_number] => 09/988686 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 39958 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20030120052.pdf [firstpage_image] =>[orig_patent_app_number] => 09988686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750439 [patent_doc_number] => 20030044959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes' [patent_app_type] => new [patent_app_number] => 09/988626 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 39968 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044959.pdf [firstpage_image] =>[orig_patent_app_number] => 09988626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688442 [patent_doc_number] => 20030032167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Secreted alpha-helical protein zlmda24' [patent_app_type] => new [patent_app_number] => 10/038241 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39072 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032167.pdf [firstpage_image] =>[orig_patent_app_number] => 10038241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6687939 [patent_doc_number] => 20030031664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Composition and method for enhancing fibrinolysis\n' [patent_app_type] => new [patent_app_number] => 09/977283 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23559 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031664.pdf [firstpage_image] =>[orig_patent_app_number] => 09977283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779388 [patent_doc_number] => 20030050470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Biomarkers and targets for diagnosis, prognosis and management of prostate disease, bladder and breast cancer' [patent_app_type] => new [patent_app_number] => 09/974546 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 43487 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050470.pdf [firstpage_image] =>[orig_patent_app_number] => 09974546 [rel_patent_id] =>[rel_patent_doc_number] =>)